Probiotic and milk technological properties of Lactobacillus brevis

International Journal of Food Microbiology

Volumn 83, Issue 1, 2003, Pages 63-74

  Rönkä, Elina ^a   Malinen, Erja ^a   Saarela, Maria ^b   Rinta Koski, Merja ^a   Aarnikunnas, Johannes ^a   Palva, Airi ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b VTT TECHNICAL RESEARCH CENTRE OF FINLAND   (Finland)

Author keywords

Lactobacillus brevis; Milk; Probiotic supplement

Indexed keywords

BILE ACID; PROBIOTIC AGENT; VANCOMYCIN; YOGHURT;

ACID TOLERANCE; ACIDIFICATION; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; ASSAY; BACILLUS CEREUS; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERIUM ADHERENCE; CELL STRAIN CACO 2; CONTROLLED STUDY; CRYOPRESERVATION; DAIRY PRODUCT; FECES ANALYSIS; FOOD COMPOSITION; GASTROINTESTINAL TRACT; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; INTESTINE CELL; LACTOBACILLUS BREVIS; MILK; NONHUMAN; NORMAL HUMAN; PANCREAS JUICE; STRAIN DIFFERENCE;

BACILLUS CEREUS; LACTOBACILLUS BREVIS;

EID: 0037466729     PISSN: 01681605     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1605(02)00315-X     Document Type: Article

References (34)

1. Arthur M., Reynolds P., Courvalin P. Glycopeptide resistance in enterococci. Trends in Microbiology. 4(10):1996;401-407.
2. Charteris W.P., Kelly P.M., Morelli L., Collins J.K. Antibiotic susceptibility of potentially probiotic Lactobacillus species. Journal of Food Protection. 61:1998;1636-1643.
3. Clark P.A., Cotton L.N., Martin J. Selection of bifidobacteria for use as dietary adjuncts in cultured dairy foods: II - tolerance to simulated pH of human stomachs. Cultured Dairy Products Journal. 28(4):1993;11-14.
4. Collins J.K., Thornton K., Sullivan G.O. Selection of probiotic strains for human applications. International Dairy Journal. 8:1998;487-490.
5. Dunne C., Murphy L., Flynn S., O'Mahony L., O'Halloran S., Feeney M., Morrissey D., Thornton G., Fitzgerald G., Daly C., Kiely B., Quigley E.M.M., O'Sullivan G.C., Shanahan F., Kevin J. Probiotics: from myth to reality. Demonstration of functionality in animal models of disease and in human clinical trials. Antonie van Leeuwenhoek. 76:1999;279-292.
6. 2 production and antibiotic resistance and correlation with human clinical status. Journal of Clinical Microbiology. 37(3):1999;729-733.
7. Gilliland S.E., Staley T.E., Bush L.J. Importance of bile tolerance of Lactobacillus acidophilus used as a dietery adjunct. Journal of Dairy Science. 67:1984;3045-3051.
8. Greene J.D., Klaenhammer T.R. Factors involved in adherence of lactobacilli to human Caco-2 cells. Applied and Environmental Microbiology. 60(12):1994;4487-4494.
9. Hartemink R., Domenech V.R., Rombouts F.M. LAMVAB - a new selective medium for the isolation of lactobacilli from faeces. Journal of Microbiological Methods. 29:1997;77-84.
10. Herrero M., Mayo B., González B., Suárez J.E. Evaluation of technologically important traits in lactic acid bacteria isolated from spontaneous fermentations. Journal of Applied Bacteriology. 81:1996;565-570.
11. Hynönen U., Westerlund-Wikström B., Palva A., Korhonen T.K. Identification by flagellum display of an epithelial cell- and fibronectin-binding function in the SlpA surface protein of Lactobacillus brevis. Journal of Bacteriology. 184(12):2002;3360-3367.
12. Jacobsen C.N., Rosenfeldt Nielsen V., Hayford A.E., Møller P.L., Michaelsen K.F., Pærregaard A., Sandström B., Tvede M., Jakobsen M. Screening of probiotic activities of forty-seven strains of Lactobacillus spp. by in vitro techniques and evaluation of the colonization ability of five selected strains in humans. Applied and Environmental Microbiology. 65(11):1999;4949-4956.
13. Kahala M., Palva A. The expression signals of the Lactobacillus brevis slpA gene direct efficient heterologous protein production in lactic acid bacteria. Applied Microbiology and Biotechnology. 51:1999;71-78.
14. Kahala M., Savijoki K., Palva A. In vivo expression of the Lactobacillus brevis S-layer gene. Journal of Bacteriology. 179(1):1997;284-286.
15. Kandler O., Weiss N. Regular, nonsporing gram-positive rods. Bergey's Manual of Systematic Bacteriology. vol. 2:1986;1208-1260 Williams & Wilkins, Baltimore.
16. Kimoto H., Kurisaki J., Tsuji N.M., Ohmomo S., Okamoto T. Lactococci as probiotic strains: adhesion to human enterocyte-like Caco-2 cells and tolerance to low pH and bile. Letters in Applied Microbiology. 29:1999;313-316.
17. Kishi A., Kazuko U., Matsubara Y., Okuda C., Kishida T. Effect of oral administration of Lactobacillus brevis subsp. Coagulans on interferon-α producing capacity of humans. Journal of the American College of Nutrition. 15(4):1996;408-412.
18. Klein G., Hallman C., Casas I.A., Abad J., Louwers J., Reuter G. Exclusion of vanA, vanB and vanC type glycopeptide resistance in strains of Lactobacillus reuteri and Lactobacillus rhamnosus used as probiotics by polymerase chain reaction and hybridization methods. Journal of Applied Microbiology. 89:2000;815-824.
19. Koga T., Mizobe T., Takumi K. Antibacterial activity of Lactobacillus species against Vibrio species. Microbiology Research. 153:1998;271-275.
20. Lee Y.-K., Salminen S. The coming of age of probiotics. Trends in Food Science and Technology. 6:1995;241-245.
21. Lehto E.M., Salminen S. Adhesion of two Lactobacillus strains, one Lactococcus and one Propionibacterium strain to cultured human intestinal Caco-2 cell line. Bioscience Microflora. 16(1):1997;13-17.
22. Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria; Approved Standard - Fourth edition. NCCLS document M11-A4, 17(22), December 1997.
23. Orla-Jensen S. The Lactic Acid Bacteria. 1919;Host & Son, Copenhagen.
24. O'Sullivan M.G., Thornton G., O'Sullivan G.C., Collins J.K. Probiotic bacteria: myth or reality? Trends in Food Science and Technology. 3:1992;309-314.
25. Ouwehand A.C., Isolauri E., Kirjavainen P.V., Salminen S.J. Adhesion of four Bifidobacterium strains to human intestinal mucus from subjects in different age groups. FEMS Microbiology Letters. 172:1999;61-64.
26. Ouwehand A.C., Niemi P., Salminen S.J. The normal faecal microflora does not affect the adhesion of probiotic bacteria in vitro. FEMS Microbiology Letters. 177:1999;35-38.
27. Ouwehand A.C., Tuomola E.M., Tölkkö S., Salminen S. Assessment of adhesion properties of novel probiotic strains to human intestinal mucus. International Journal of Food Microbiology. 64:2001;119-126.
28. Salminen S., von Wright A., Morelli L., Marteau P., Brassart D., de Vos W.M., Fondén R., Saxelin M., Collins K., Mogensen G., Birkeland S.-E., Mattila-Sandholm T. Demonstration of safety of probiotics - a review. International Journal of Food Microbiology. 44(1-2):1998;93-106.
29. Sarem F., Sarem-Damerdji L.O., Nicolas J.P. Comparison of the adherence of three Lactobacillus strains to Caco-2 and Int-407 intestinal human cell lines. Letters in Applied Microbiology. 22:1996;439-442.
30. Savijoki K., Kahala M., Palva A. High level heterologous protein production in Lactococcus and Lactobacillus using a new secretion system based on the Lactobacillus brevis S-layer signals. Gene. 186:1997;255-262.
31. Swenson J.M., Facklam R.R., Thornsberry C. Antimicrobial susceptibility of vancomycin-resistant Leuconostoc, Pediococcus, and Lactobacillus species. Antimicrobial Agents and Chemotherapy. 34(4):1990;543-549.
32. Tynkkynen S., Singh K.V., Varmanen P. Vancomycin resistance factor of Lactobacillus rhamnosus GG in relation to enterococcal vancomycin resistance (van) genes. International Journal of Food Microbiology. 41:1998;195-204.
33. Vidgrén G., Palva I., Pakkanen R., Lounatmaa K., Palva A. S-layer protein gene of Lactobacillus brevis: cloning by polymerase chain reaction and determination of the nucleotide sequence. Journal of Bacteriology. 174(22):1992;7419-7427.
34. Zarazaga M., Sáenz Y., Portillo A., Tenorio C., Ruiz-Larrea F., Del Campo R., Baquero F., Torres C. In vitro activities of ketolide HMR3647, macrolides, and other antibiotics against Lactobacillus, Leuconostoc, and Pediococcus isolates. Antimicrobial Agents and Chemotherapy. 43(12):1999;3041-3049.